Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tilanus

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Respiratory Research|July 27, 2017
The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosisT B M Tilanus, J T Groothuis, J M C TenBroek-Pastoor, et al.
Lancet (London, England)|July 8, 2000
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutationE J Meijers-Heijboer, L C Verhoog, C T Brekelmans, et al.
International Journal of Cancer|March 31, 2015
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial riskC T Brekelmans, C Seynaeve, C C Bartels, et al.
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer familiesL C Verhoog, A M van den Ouweland, E Berns, et al.
International Journal of Cancer|May 3, 2014
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort studySepideh Saadatmand, Janet R Vos, Maartje J Hooning, et al.
Clinical and Experimental Immunology|January 6, 2015
Follicular T helper cells and humoral reactivity in kidney transplant patientsG N de Graav, M Dieterich, D A Hesselink, et al.
Leukemia|March 8, 2012
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantationT Lion, F Watzinger, S Preuner, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Respiratory Research|July 27, 2017
The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosisT B M Tilanus, J T Groothuis, J M C TenBroek-Pastoor, et al.
Lancet (London, England)|July 8, 2000
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutationE J Meijers-Heijboer, L C Verhoog, C T Brekelmans, et al.
International Journal of Cancer|March 31, 2015
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial riskC T Brekelmans, C Seynaeve, C C Bartels, et al.
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer familiesL C Verhoog, A M van den Ouweland, E Berns, et al.
International Journal of Cancer|May 3, 2014
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort studySepideh Saadatmand, Janet R Vos, Maartje J Hooning, et al.
Clinical and Experimental Immunology|January 6, 2015
Follicular T helper cells and humoral reactivity in kidney transplant patientsG N de Graav, M Dieterich, D A Hesselink, et al.
Leukemia|March 8, 2012
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantationT Lion, F Watzinger, S Preuner, et al.
Pageof 6